Risk factors for recurrence after successful treatment of Mycobacterium avium complex lung disease

Antimicrobial Agents and Chemotherapy

Volumn 59, Issue 6, 2015, Pages 2972-2977

  Lee, Bo Young ^a   Kim, Sunyoung ^b   Hong, YoonKi ^c   Lee, Sang Do ^a   Kim, Woo Sung ^a   Kim, Dong Soon ^a   Shim, Tae Sun ^a   Jo, Kyung Wook ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Inje University College of Medicine   (South Korea)

^c Kangwon National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; ETHAMBUTOL; RIFAMPICIN; STREPTOMYCIN; AMINOGLYCOSIDE; ANTIINFECTIVE AGENT; MACROLIDE;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; ATYPICAL MYCOBACTERIOSIS; FEMALE; FOLLOW UP; HUMAN; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MYCOBACTERIUM AVIUM; MYCOBACTERIUM INTRACELLULARE; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT DISEASE; RISK FACTOR; SOUTH KOREA; TERTIARY CARE CENTER; TREATMENT DURATION; TREATMENT OUTCOME; AGED; DRUG EFFECTS; LUNG DISEASES; MIDDLE AGED; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION; PATHOGENICITY; RETROSPECTIVE STUDY;

AGED; AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; FEMALE; HUMANS; LUNG DISEASES; MACROLIDES; MALE; MIDDLE AGED; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84929589717     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.04577-14     Document Type: Article

References (28)

1. Xu HB, Jiang RH, Li L. 2014. Treatment outcomes for Mycobacterium avium complex: a systematic review and meta-analysis. Eur J Clin Microbiol Infect Dis 33:347-358. http://dx.doi.org/10.1007/s10096-013-1962-1.
2. Yoo JW, Jo KW, Kim MN, Lee SD, Kim WS, Kim DS, Shim TS. 2012. Increasing trend of isolation of non-tuberculous mycobacteria in a tertiary university hospital in South Korea. Tuberc Respir Dis (Seoul) 72:409-415. http://dx.doi.org/10.4046/trd.2012.72.5.409.
3. Kartalija M, Ovrutsky AR, Bryan CL, Pott GB, Fantuzzi G, Thomas J, Strand MJ, Bai X, Ramamoorthy P, Rothman MS, Nagabhushanam V, McDermott M, Levin AR, Frazer-Abel A, Giclas PC, Korner J, Iseman MD, Shapiro L, Chan ED. 2013. Patients with nontuberculous mycobacterial lung disease exhibit unique body and immune phenotypes. Am J Respir Crit Care Med 187:197-205. http://dx.doi.org/10.1164/rccm.201206-1035OC.
4. Koh WJ, Jeong BH, Jeon K, Lee NY, Lee KS, Woo SY, Shin SJ, Kwon OJ. 2012. Clinical significance of the differentiation between Mycobacterium avium and Mycobacterium intracellulare in M. avium complex lung disease. Chest 142:1482-1488. http://dx.doi.org/10.1378/chest.12-0494.
5. Field SK, Fisher D, Cowie RL. 2004. Mycobacterium avium complex pulmonary disease in patients without HIV infection. Chest 126:566-581. http://dx.doi.org/10.1378/chest.126.2.566.
6. Kobashi Y, Matsushima T, Oka M. 2007. A double-blind randomized study of aminoglycoside infusion with combined therapy for pulmonary Mycobacterium avium complex disease. Respir Med 101:130-138. http://dx.doi.org/10.1016/j.rmed.2006.04.002.
7. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, Iseman M, Olivier K, Ruoss S, von Reyn CF, Wallace RJ, Jr, Winthrop K. 2007. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 175:367-416. http://dx.doi.org/10.1164/rccm.200604-571ST.
8. Hayashi M, Takayanagi N, Kanauchi T, Miyahara Y, Yanagisawa T, Sugita Y. 2012. Prognostic factors of 634 HIV-negative patients with Mycobacterium avium complex lung disease. Am J Respir Crit Care Med 185:575-583. http://dx.doi.org/10.1164/rccm.201107-1203OC.
9. Woods GL, Brown-Elliott B, Conville P, Desmond EP, Hall GS, Lin G, Pfyffer GE, Ridderhof JC, Siddiqi SH, Wallace RJ, Warren NG, Witebsky FG. 2011. Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes; approved standard M24A2E. Document no. M24-A22. Clinical and Laboratory Standards Institute, Wayne, PA.
10. Sim YS, Park HY, Jeon K, Suh GY, Kwon OJ, Koh WJ. 2010. Standardized combination antibiotic treatment of Mycobacterium avium complex lung disease. Yonsei Med J 51:888-884. http://dx.doi.org/10.3349/ymj.2010.51.6.888.
11. Chang KC, Leung CC, Yew WW, Ho SC, Tam CM. 2004. A nested case-control study on treatment-related risk factors for early relapse of tuberculosis. Am J Respir Crit Care Med 170:1124-1130. http://dx.doi.org/10.1164/rccm.200407-905OC.
12. Chang KC, Leung CC, Yew WW, Chan SL, Tam CM. 2006. Dosing schedules of 6-month regimens and relapse for pulmonary tuberculosis. Am J Respir Crit Care Med 174:1153-1158. http://dx.doi.org/10.1164/rccm.200605-637OC.
13. Jo KW, Yoo JW, Hong Y, Lee JS, Lee SD, Kim WS, Kim DS, Shim TS. 2014. Risk factors for 1-year relapse of pulmonary tuberculosis treated with a 6-month daily regimen. Respir Med 108:654-659. http://dx.doi.org/10.1016/j.rmed.2014.01.010.
14. Lambert M-L, Hasker E, Deun AV, Roberfroid D, Boelaert M, Van der Stuyft P. 2003. Recurrence in tuberculosis: relapse or reinfection? Lancet Infect Dis 3:282-287. http://dx.doi.org/10.1016/S1473-3099(03)00607-8.
15. Colombo RE, Hill SC, Claypool RJ, Holland SM, Olivier KN. 2010. Familial clustering of pulmonary nontuberculous mycobacterial disease. Chest 137:629-634. http://dx.doi.org/10.1378/chest.09-1173.
16. Wallace RJ, Jr, Zhang Y, Brown BA, Dawson D, Murphy DT, Wilson R, Griffith DE. 1998. Polyclonal Mycobacterium avium complex infections in patients with nodular bronchiectasis. Am J Respir Crit Care Med 158:1235-1244. http://dx.doi.org/10.1164/ajrccm.158.4.9712098.
17. Wallace RJ, Jr, Zhang Y, Brown-Elliott BA, Yakrus MA, Wilson RW, Mann L, Couch L, Girard WM, Griffith DE. 2002. Repeat positive cultures in Mycobacterium intracellulare lung disease after macrolide therapy represent new infections in patients with nodular bronchiectasis. J Infect Dis 186:266-273. http://dx.doi.org/10.1086/341207.
18. Wallace RJ, Jr, Brown-Elliott BA, McNulty S, Philley JV, Killingley J, Wilson RW, York DS, Shepherd S, Griffith DE. 2014. Macrolide/azalide therapy for nodular/bronchiectatic Mycobacterium avium complex lung disease. Chest 146:276-282. http://dx.doi.org/10.1378/chest.13-2538.
19. Wallace RJ, Jr, Brown BA, Griffith DE, Girard WM, Murphy DT. 1996. Clarithromycin regimens for pulmonary Mycobacterium avium complex. The first 50 patients. Am J Respir Crit Care Med 153:1766-1772. http://dx.doi.org/10.1164/ajrccm.153.6.8665032.
20. Roussel G, Igual J. 1998. Clarithromycin with minocycline and clofazimine for Mycobacterium avium intracellulare complex lung disease in patients without the acquired immune deficiency syndrome. GETIM. Groupe d'Etude et de Traitement des Infections à Mycobactéries. Int J Tuberc Lung Dis 2:462-470.
21. Tanaka E, Kimoto T, Tsuyuguchi K, Watanabe I, Matsumoto H, Niimi A, Suzuki K, Murayama T, Amitani R, Kuze F. 1999. Effect of clarithromycin regimen for Mycobacterium avium complex pulmonary disease. Am J Respir Crit Care Med 160:866-872. http://dx.doi.org/10.1164/ajrccm.160.3.9811086.
22. Huang JH, Kao PN, Adi V, Ruoss SJ. 1999. Mycobacterium avium-intracellulare pulmonary infection in HIV-negative patients without preexisting lung disease: diagnostic and management limitations. Chest 115:1033-1040. http://dx.doi.org/10.1378/chest.115.4.1033.
23. Field SK, Cowie RL. 2003. Treatment of Mycobacterium avium-intracellulare complex lung disease with a macrolide, ethambutol, and clofazimine. Chest 124:1482-1486. http://dx.doi.org/10.1378/chest.124.4.1482.
24. Jo KW, Kim S, Lee JY, Lee SD, Kim WS, Kim DS, Shim TS. 2014. Treatment outcomes of refractory MAC pulmonary disease treated with drugs with unclear efficacy. J Infect Chemother 20:602-606. http://dx.doi.org/10.1016/j.jiac.2014.05.010.
25. Koh WJ, Hong G, Kim SY, Jeong BH, Park HY, Jeon K, Kwon OJ, Lee SH, Kim CK, Shin SJ. 2013. Treatment of refractory Mycobacterium avium complex lung disease with a moxifloxacin-containing regimen. Antimicrob Agents Chemother 57:2281-2285. http://dx.doi.org/10.1128/AAC.02281-12.
26. Griffith DE, Aksamit TR. 2012. Therapy of refractory nontuberculous mycobacterial lung disease. Curr Opin Infect Dis 25:218-227. http://dx.doi.org/10.1097/QCO.0b013e3283511a64.
27. Lam PK, Griffith DE, Aksamit TR, Ruoss SJ, Garay SM, Daley CL, Catanzaro A. 2006. Factors related to response to intermittent treatment of Mycobacterium avium complex lung disease. Am J Respir Crit Care Med 173:1283-1289. http://dx.doi.org/10.1164/rccm.200509-1531OC.
28. Kim EY, Chi SY, Oh IJ, Kim KS, Kim YI, Lim SC, Kim YC, Kwon YS. 2011. Treatment outcome of combination therapy including clarithromycin for Mycobacterium avium complex pulmonary disease. Korean J Intern Med 26:54-59. http://dx.doi.org/10.3904/kjim.2011.26.1.54.